DFDA

Surgical Coarctation of Aorta Repair

Treatment for Congenital Heart Anomalies

Effectiveness
95%
Safety Score
50%
Clinical Trials
4
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (pressure gradient relieved), blood pressure normalization over days-weeks
Treatment Duration
Single procedure, lifetime monitoring (especially for hypertension)
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$750
Side Effect Mgmt:$100
Total Annual:$950
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
15
Outcome-Based Costs
Cost per Responder
$1,000
Cost per Remission
$1,055.56
Surgical Coarctation of Aorta Repair Outcomes

for Congenital Heart Anomalies

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Recurrent coarctation
+5%
Paradoxical hypertension
+10%
Spinal cord ischemia/paraplegia
+0.1%
Chylothorax
+2%
Nerve injury (recurrent laryngeal, phrenic)
+2%
Mortality
+1%

Sources:

researchgate.net
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Surgical Coarctation of Aorta Repair in Congenital Heart Anomalies

Correlation of Cardiac Index Measured by the PRAM Method With NIRS and Lactate Levels in Pediatric Aortic Coarctation Surgery

NCT07568431NOT YET RECRUITING
View Study
43 participants
OBSERVATIONAL
Konya, Turkey (Türkiye)
Started: May 1, 2026